With consistent dosing and reasonable lifestyle support, most patients hit this milestone between months three and five
however, the market scenario has shifted focus towards oral GLP-1 receptor agonists, incretin agonists, triple agonists, and amylin-based approaches targeting obesity as a metabolic disease rather than merely focusing on its weight management
do not prescribe more than one months supply unless there is clear reason to do so
#glp1 #glp1community #momsover30 #glp1girlies #insulinresistance #sahm @Join Amble On a GLP-1
The results show that women tend to use GLP-1 drugs at higher rates than men, although there is considerable variability within age groups
These two changes are helpful for many people, but they may be difficult to maintain